News

Immutep Secures Third United States Patent for Eftilagimod Alpha in Combination with a PD-1 Pathway Inhibitor

Posted: 28 June 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announced the grant of a new patent (number 11,684,654) entitled “Combined Preparations for the Treatment of…

New national venture strengthens home-grown medicine outcomes

Posted: 28 June 2023 The Medical Research Future Fund (MRFF) has invested $9.75 million into establishing MedChem Australia, a new national medicinal chemistry initiative. At a glance MRFF National Critical Research Infrastructure Grant invests $9.75 million to establish…

Finding rewrites understanding into Parkinson’s disease pathway

Posted: 28 June 2023 Researchers have solved a long-standing mystery about how a protein helps rid the body of damaged mitochondria, in findings that could help lead to potential new treatments for Parkinson’s disease. At a glance Discovery…

Cumming Global Centre for Pandemic Therapeutics receives $5 million grant from The Ian Potter Foundation

Posted: 28 June 2023 The Cumming Global Centre for Pandemic Therapeutics (Cumming Global Centre) has received a generous $5 million seed grant from one of Australia’s leading philanthropic organisations, The Ian Potter Foundation. Launched in August 2022, the Doherty Institute’s Cumming…

Excellent Clinical Data For SubB2M/CA15-3 Breast Cancer Test

Posted: 27 July 2023 INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a developer of next-generation exosome solutions and precision diagnostics, is pleased to announce excellent results from an independent clinical validation study of its SubB2M/CA15-3 test for breast…

Immuron to go ahead with IMM-529 cGMP manufacturing and proceed with FDA pre-IND submission

Posted: 27 June 2023 The Board of Directors of Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has given the green light for the company to proceed with IMM-529 cGMP manufacturing for the treatment of a form of gastrointestinal disease. Directors have also approved…

Australian invention for potential treatment of anxiety disorders initiates Phase 2a Clinical Trial

Posted: 27 July 2023 A unique drug delivery platform developed by Monash University researchers in partnership with PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), has reached another exciting milestone, with the initiation of a Phase 2a clinical trial of LYT-300…

Avecho passes two-year stability milestone for its pharmaceutical CBD soft-gel capsule

Posted: 27 June 2023 Avecho Biotechnology Limited (ASX:AVE, “Avecho”, or “the Company”) has today announced it has passed a crucial two–year stability point milestone for its TPM®–enhanced cannabidiol (“CBD”) soft–gel capsule. Cannabinoids are susceptible to degradation from a…

Imagion set to complete the MagSense HER2 Phase 1 Study

Posted: 21 June 2023 Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that the MagSense® HER2 imaging agent Phase 1 study (IBI10103) has achieved its enrolment…

Immutep Granted United States Patent for IMP761, a First-in-Class Agonist Antibody Targeting LAG-3

Posted: 21 June 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announced the grant of a new patent (number 11,680,104) by the United States Patent Office.…

Rhythm Continues Platform Expansion Program for Other Cancers

Posted: 21 June 2023 Transformative cancer diagnostic technology, Rhythm Biosciences Ltd is pleased to provide an update regarding the technical feasibility pipeline expansion initiatives/opportunities. As previously announced, the Company has identified several other critical cancers where it can…

Vaccine Innovation Trends Report: Global Vaccine Research and Development Pipeline and Delivery Implications

Posted: 19 June 2023 Vaccines are essential to global public health — available to prevent more than 20 diseases, vaccines avert 3.5 to 5 million deaths each year and combat emerging infectious diseases and the spread of microbial…

Home

News & opinion

Member Directory

Events